Walleye Trading’s Array Biopharma Inc ARRY Stock Holding History

Walleye Trading’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-78,038	Closed	-$3.62M	–	4700
2019 Q2	$3.62M	Buy	78,038 +72,258	+1,250%	+$2.03M	0.03%	644
2019 Q1	$141K	Buy	5,780 +2,845	+97%	+$59.2K	﹤0.01%	3279
2018 Q4	$42K	Buy	+2,935	New	+$44.5K	﹤0.01%	4196
2016 Q2	–	Sell	-3,000	Closed	-$9K	–	5940
2016 Q1	$9K	Buy	+3,000	New	+$8.99K	﹤0.01%	4786
2015 Q4	–	Sell	-200	Closed	-$1K	–	5938
2015 Q3	$1K	Buy	+200	New	+$1.19K	﹤0.01%	4861

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Walleye Trading's ARRY Position: Q3 2019 in Review

Walleye Trading sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 78,038 shares — an estimated $3.62M sold.

Walleye Trading first reported a position in ARRY in Q3 2015 and held it in 5 quarters. The position peaked at $3.62M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

Walleye Trading reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
Walleye Trading sold 78,038 Array Biopharma Inc shares in Q3 2019, an estimated $3.62M.
Walleye Trading first reported a position in Array Biopharma Inc in Q3 2015 and held it in 5 quarters.
Walleye Trading's Array Biopharma Inc position peaked at $3.62M in Q2 2019.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Walleye Trading's 13F filing for Q3 2019, filed 14 Nov 2019.